Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2010 2
2011 2
2013 3
2014 4
2015 3
2016 2
2017 3
2018 12
2019 7
2020 6
2021 14
2022 17
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.
Liu X, Zhou H, Hu Y, Yin J, Li J, Chen W, Huang R, Gong Y, Luo C, Mei H, Ding B, Gu C, Sun H, Leng Y, Ji D, Li Y, Yin H, Shi H, Chen K, Wang J, Fan S, Su W, Yang R. Liu X, et al. Among authors: yin h. Lancet Haematol. 2023 Jun;10(6):e406-e418. doi: 10.1016/S2352-3026(23)00034-0. Epub 2023 Apr 4. Lancet Haematol. 2023. PMID: 37028433 Clinical Trial.
Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Yin H, Yao Q, Xie Y, Niu D, Jiang W, Cao H, Feng X, Li Y, Li Y, Zhang X, Shen L, Chen Y. Yin H, et al. Cancer Med. 2023 Oct;12(19):19633-19643. doi: 10.1002/cam4.6597. Epub 2023 Sep 25. Cancer Med. 2023. PMID: 37749981 Free PMC article.
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors.
Song Y, Cao J, Zhang Q, Li C, Qiu L, Qi J, Zhang H, Li W, Liu L, Jing H, Zhou K, Zhang W, Zhang L, Li D, Zou L, Yang H, Qian W, Zhou H, Hu J, Yin H, Fu S, Fan S, Xu Q, Wang J, Jia X, Dai G, Su W, Zhu J. Song Y, et al. Among authors: yin h. Haematologica. 2024 Jan 18. doi: 10.3324/haematol.2022.282401. Online ahead of print. Haematologica. 2024. PMID: 38235512 Free article.
90 results